Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinton Veteran DeParle Brings Medicare, Budget Pragmatism To White House

This article was originally published in The Pink Sheet Daily

Executive Summary

Sebelius-DeParle team fuses elected government manager with insurance knowledge with Washington health professional with hands-on budget and Medicare/Medicaid experience.

You may also be interested in...



People In The News – Tracking The Latest Industry Personnel Moves

New top leadership at BrainStorm Cell Therapeutics, Rexahn Pharmaceuticals; BioInvent seeking new CEO; Clancy steps down as AHRQ director; co-founders from Anacor Pharmaceuticals and InVivo Therapeutics recognized by White House. More personnel announcements in this month’s column.

Sebelius Voices Support For Public Health Plan Option Before HELP Committee

HHS Secretary-designate Sebelius does not want to see employer-based health care system dismantled, but supports a public option to compete for beneficiaries in a health exchange system.

Sebelius Voices Support For Public Health Plan Option Before HELP Committee

HHS Secretary-designate Sebelius does not want to see employer-based health care system dismantled, but supports a public option to compete for beneficiaries in a health exchange system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel